Inflation-adjusted analysis of ICER’s Unsupported Price Increase reports: contextualizing drug spending changes
This study demonstrates that inflation adjustment can alter not only the findings but also the interpretation of drug spending changes in UPI reports. The findings highlight the importance of considering economic context in evaluating drug pricing trends and suggest that unadjusted figures may overstate the impact of real price changes. Given the influence of these reports on policy discussions, incorporating inflation adjustments into analyses is one of many steps toward informing evidence-based policy decisions.
Authors
- Robert J. Nordyke (ORCID: https://orcid.org/0000-0003-2424-7852)
- Jonathan D. Campbell (ORCID: https://orcid.org/0000-0001-6539-1258)
- Tyler D. Wagner (ORCID: https://orcid.org/0000-0001-7248-4890)
- Kimberly D. Westrich (ORCID: https://orcid.org/0000-0001-9392-7670)
Institutions
- National Research Council (LK)
- National Health Council (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1080/13696998.2024.2428109
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00